rs1461382798
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000321.3(RB1):c.1422-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000706 in 1,415,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000321.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- hereditary retinoblastomaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
- retinoblastomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- melanomaInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000321.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RB1 | NM_000321.3 | MANE Select | c.1422-1G>A | splice_acceptor intron | N/A | NP_000312.2 | |||
| RB1 | NM_001407165.1 | c.1422-1G>A | splice_acceptor intron | N/A | NP_001394094.1 | ||||
| RB1 | NM_001407166.1 | c.1422-1G>A | splice_acceptor intron | N/A | NP_001394095.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RB1 | ENST00000267163.6 | TSL:1 MANE Select | c.1422-1G>A | splice_acceptor intron | N/A | ENSP00000267163.4 | |||
| RB1 | ENST00000467505.6 | TSL:1 | n.*790-1G>A | splice_acceptor intron | N/A | ENSP00000434702.1 | |||
| RB1 | ENST00000650461.1 | c.1422-1G>A | splice_acceptor intron | N/A | ENSP00000497193.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome AF: 7.06e-7 AC: 1AN: 1415758Hom.: 0 Cov.: 31 AF XY: 0.00000142 AC XY: 1AN XY: 702940 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Retinoblastoma Pathogenic:2
Case and Pedigree Information: BILATERAL CASES:1, UNILATERAL CASES:0, TOTAL CASES:1, PEDIGREES:1. ACMG Codes Applied:PVS1, PM2
This sequence change affects an acceptor splice site in intron 15 of the RB1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with bilateral retinoblastoma (PMID: 15884040, Invitae). This variant is also known as c.1560-1G>A in the literature. ClinVar contains an entry for this variant (Variation ID: 527931). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RB1 are known to be pathogenic (PMID: 17096365). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at